Overview

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

Status:
Completed
Trial end date:
2020-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if tofacitinib is safe and effective in subjects with active ankylosing spondylitis.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Tofacitinib